6.38
Schlusskurs vom Vortag:
$6.14
Offen:
$6.14
24-Stunden-Volumen:
127.32K
Relative Volume:
0.91
Marktkapitalisierung:
$242.14M
Einnahmen:
$239.40M
Nettoeinkommen (Verlust:
$104.44M
KGV:
2.1554
EPS:
2.96
Netto-Cashflow:
$-18.50M
1W Leistung:
+0.16%
1M Leistung:
-10.39%
6M Leistung:
-49.12%
1J Leistung:
-62.71%
Entrada Therapeutics Inc Stock (TRDA) Company Profile
Firmenname
Entrada Therapeutics Inc
Sektor
Branche
Telefon
857-305-1825
Adresse
ONE DESIGN CENTER PLACE, BOSTON
Vergleichen Sie TRDA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
TRDA
Entrada Therapeutics Inc
|
6.38 | 241.76M | 239.40M | 104.44M | -18.50M | 2.96 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Entrada Therapeutics Inc Stock (TRDA) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-12-06 | Eingeleitet | ROTH MKM | Buy |
2024-01-05 | Eingeleitet | Oppenheimer | Outperform |
2023-04-03 | Eingeleitet | H.C. Wainwright | Buy |
Entrada Therapeutics Inc Aktie (TRDA) Neueste Nachrichten
What analysts say about Entrada Therapeutics Inc. stockSuperior trading gains - jammulinksnews.com
What drives Entrada Therapeutics Inc. stock priceFree Investment Community - Autocar Professional
Is Entrada Therapeutics Inc. a good long term investmentHigh-octane financial growth - jammulinksnews.com
Entrada Therapeutics Inc. Stock Analysis and ForecastStrongest growth potential - jammulinksnews.com
How Entrada Therapeutics Inc. stock performs during market volatilityGrowth Optimized Stock Radar - Newser
What makes Entrada Therapeutics Inc. stock price move sharplyFree Stock Investment Growth Plan - Newser
Why Entrada Therapeutics Inc. stock attracts strong analyst attentionControlled Risk High Reward Plan - Newser
Allspring Global Investments Holdings LLC Has $149,000 Stock Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World
Entrada Therapeutics, Inc. (NASDAQ:TRDA) Shares Purchased by Allspring Global Investments Holdings LLC - Defense World
Major Stock Sell-Offs at Entrada Therapeutics: What You Need to Know! - TipRanks
5am Ventures v sells Entrada Therapeutics (TRDA) stock for $202k - Investing.com Nigeria
5am Ventures v sells Entrada Therapeutics (TRDA) stock for $202k By Investing.com - Investing.com South Africa
Entrada therapeutics (TRDA) director Parmar sells $202k in stock By Investing.com - Investing.com South Africa
Entrada therapeutics (TRDA) director Parmar sells $202k in stock - Investing.com Australia
(TRDA) Investment Analysis and Advice - news.stocktradersdaily.com
Entrada Therapeutics (NASDAQ:TRDA) Shares Down 3.6% – Should You Sell? - Defense World
Entrada Therapeutics (TRDA) 10% owners sell $866k in stock - Investing.com
Entrada Therapeutics (NASDAQ:TRDA) Upgraded to “Hold” at Wall Street Zen - Defense World
(TRDA) Long Term Investment Analysis - news.stocktradersdaily.com
Harbor Capital Advisors Inc. Makes New Investment in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World
Wall Street Zen Downgrades Entrada Therapeutics (NASDAQ:TRDA) to Sell - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 21,594 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World
Millennium Management LLC Sells 98,416 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World
Entrada Therapeutics Holds Virtual Annual Stockholders Meeting - TipRanks
Entrada Therapeutics, Inc. (NASDAQ:TRDA) Holdings Raised by Bank of America Corp DE - Defense World
Transcript : Entrada Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 08 - MarketScreener
Mackenzie Financial Corp Makes New Investment in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World
How the (TRDA) price action is used to our Advantage - news.stocktradersdaily.com
Entrada Therapeutics, Inc. (NASDAQ:TRDA) Stock Position Trimmed by Nuveen Asset Management LLC - Defense World
Entrada Therapeutics expands board with new director By Investing.com - Investing.com South Africa
Finanzdaten der Entrada Therapeutics Inc-Aktie (TRDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):